The 20 Best Acute Lymphoblastic Leukemia (ALL) Doctors Near Me in Ann Arbor, MI

Dr. Dale Bixby has been practicing hematology at the University of Michigan since 2009. He obtained his PhD in Medicinal Chemistry and Pharmaceutics at the University of Kentucky in 1999, before beginning his medical training at the University of Michigan in Ann Arbor, MI. He was a resident in the Department of Internal Medicine and then completed fellowship training in hematology and medical oncology at the University of Michigan. Dr. Bixby is currently a clinical professor and specializes in the areas of myeloid and lymphoid leukemias, myelodysplastic syndrome and bone marrow failure disorders. Dr. Bixby currently serves as the section chief of the acute leukemia program. He is also a clinical investigator in hematological malignancies. Dr. Bixby is rated as a Distinguished provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Chronic Myelogenous Leukemia (CML), and Bone Marrow Aspiration.

Dr. Burke joined the faculty in July 2014. He attended Providence College in Rhode Island where he earned his BS in Biology. Subsequently, he matriculated at the Icahn School of Medicine at Mount Sinai and earned his MD. He then completed a residency in Internal Medicine at the University of Chicago Medical Center, followed by a year serving as a Chief Resident. He recently completed his Hematology/Medical Oncology fellowship at Memorial Sloan Kettering Cancer Center in New York where his clinical and research interests focused on leukemia, particularly adult acute lymphoblastic leukemia (ALL). He performed clinical research regarding the role of asparaginase and “pediatric-inspired” therapeutic regimens in adult ALL, as well as investigating therapies that spare cytotoxic chemotherapy in older adult Philadelphia chromosome-positive ALL. Dr. Burke is focused on early phase clinical trials in acute leukemias and is treating patients with hematologic malignancies. Dr. Burke is rated as a Distinguished provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Aplastic Anemia, Acute Myeloblastic Leukemia with Maturation, and Bone Marrow Aspiration.

Dr. Gregory Yanik has been a faculty member within the Blood and Marrow Transplant Program and Division at the University of Michigan since 1992. He was born and raised in the Detroit area, attended medical school at Wayne State University and trained in hematology-oncology at Cincinnati Children’s Hospital. He and his wife Marybeth have three grown children. Dr. Yanik has been the recipient of many prestigious awards in recognition of his contributions to medical research, clinical care, and education, including the Leland and Elaine Blatt Professorship of Pediatric Oncology, the University of Michigan Pediatric Teacher of the Year Award, and the Leukemia and Lymphoma Society Chairman’s Citation for Outstanding Service. Dr. Yanik is the founder of and chairs the Executive Committee for the Children’s Hematology Alliance of Michigan (CHAMI), a unique alliance of pediatric hematology/practice teams in the State of Michigan whose goal is to continuously improve the quality of care for children with these medical conditions regardless of where they are treated in the State. In addition to these many activities, Dr. Yanik makes time to serve on the Executive Committee for Make a Wish Michigan. Dr. Yanik is rated as a Distinguished provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Graft Versus Host Disease (GvHD), Acute Lymphoblastic Leukemia (ALL), and Bone Marrow Transplant.

Emily B. Walling MD, MPHS is a Clinical Assistant Professor in the Division of Hematology/Oncology, Department of Pediatrics. Dr. Walling received her bachelor's degree from the University of Wisonsin-Madison and her medical degree from the University of Toledo. Following residency training in pediatrics at the Medical College of Wisconsin, Dr. Walling completed her fellowship training in pediatric hematology-oncology at Washington University where she earned her master's degree in population health sciences. Dr. Walling joined the faculty at Michigan in 2016. She founded and is the co-medical director of the Michigan Medicine Adolescent and Young Adult Oncology Program. Dr. Walling is rated as an Advanced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). Her top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Hereditary Neuroblastoma, Neuroblastoma, Osteosarcoma, and Bone Marrow Aspiration.

Joshua Goldman is a Pediatrics provider in Ann Arbor, Michigan. Dr. Goldman has been practicing medicine for over 10 years and is rated as an Advanced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Hereditary Neuroblastoma, Neuroblastoma, Febrile Neutropenia, and Bone Marrow Aspiration.

Rama Rao is a Pediatrics provider in Ann Arbor, Michigan. Dr. Rao is rated as an Advanced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). Her top areas of expertise are Osteosarcoma, Chondrosarcoma, Neuroblastoma, Hereditary Neuroblastoma, and Bone Marrow Aspiration.

Dr. Sedig was born and raised in Orlando, Florida. She completed her undergraduate degree in Medical Ethics at Davidson College before returning to Florida to attend the University of Florida College of Medicine. She then went to the University of Wisconsin-Madison for her residency in Pediatrics and then to the University of Michigan for her Pediatric Hematology/Oncology Fellowship. Dr. Sedig is rated as an Advanced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). Her top areas of expertise are Retinoblastoma, Hepatoblastoma, Neuroblastoma, Hereditary Neuroblastoma, and Bone Marrow Aspiration.

Sarah Anand is a Hematologist and an Oncologist in Ann Arbor, Michigan. Dr. Anand is rated as an Advanced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). Her top areas of expertise are Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Colonoscopy.

John Maciejewski is a Hematologist and an Internal Medicine provider in Ann Arbor, Michigan. Dr. Maciejewski is rated as an Advanced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Graft Versus Host Disease (GvHD), Multiple Myeloma, Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Marrow Aspiration.

Jennifer Agrusa is a Pediatrics provider in Ann Arbor, Michigan. Dr. Agrusa is rated as an Advanced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). Her top areas of expertise are Hodgkin Lymphoma, Acute Lymphoblastic Leukemia (ALL), Hereditary Neuroblastoma, Neuroblastoma, and Bone Marrow Aspiration.

Attaphol Pawarode is a Hematologist and an Internal Medicine provider in Ann Arbor, Michigan. Dr. Pawarode is rated as an Advanced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Marrow Aspiration.

Dr. Ghada Abusin was born in the Sudan and grew up in the United Arab Emirates (UAE). She received her medical degree in 2001 from the University of Khartoum, Sudan. In 2003, Dr. Abusin moved to the United States. She completed her pediatric residency training at the Children’s Hospital of New Jersey in Newark Beth Israel and pediatric hematology-oncology fellowship training at the University of Iowa Children’s Hospital. She joined the pediatric faculty at the University of Iowa after graduation in August 2011 and became the Co-Director of pediatric BMT program in 2012. During her time in Iowa, Dr. Abusin obtained both Master’s degree in Clinical Investigation and Certificate in Medical Education. Dr. Abusin is the recipient of the prestigious award 40 under 40 by the Corridor Business Journal in recognition of her contributions to pediatric bone marrow transplantation in the state of Iowa. Dr. Abusin is well known for her commitment and contributions to medical education for undergraduate students, medical students, pediatric residents and pediatric hematology/oncology fellows. She has served on the institutional review board (IRB) for human research for many years, exemplifying her understanding of the significance of research in medicine and the vital importance of protecting the rights and wellbeing of human life. Dr. Abusin joined the University of Michigan as a faculty member within the Blood and Marrow Transplant Program in the Department of Pediatrics in December 2016. Dr. Abusin is rated as an Advanced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). Her top areas of expertise are Sickle Cell Disease, Thalassemia, Neuroblastoma, Beta Thalassemia, and Bone Marrow Transplant.

Dr. Pettit studied physics and magazine journalism at Syracuse University prior to earning her MD from the Chicago Medical School. She went on to complete her residency in internal medicine and fellowships in hematology/oncology and clinical pharmacology/pharmacogenomics at the University of Chicago. She has received national recognition for her research, including the Conquer Cancer Foundation/ASCO Young Investigator Award, the ASCPT Presidential Trainee Award, and selection for the ASH Clinical Research Training Institute. Dr. Pettit focuses on translational research and drug development for patients with myeloid malignancies, specifically myeloproliferative neoplasms, myelodysplastic syndrome, and acute myeloid leukemia. Dr. Pettit is rated as an Advanced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). Her top areas of expertise are Myelofibrosis, Myeloproliferative Neoplasms (MPN), Acute Myeloid Leukemia (AML), Bone Marrow Aspiration, and Splenectomy.

Monalisa Ghosh, MD, Assistant Professor. Dr. Ghosh graduated with honors from the University of Alabama at Birmingham with a BS in Biomedical Engineering, minor in Mathematics and Chemistry. She earned her MD from the University of Alabama School of Medicine where she also completed her residency training. Her fellowship training was completed at the NIH/NCI Medical Oncology Fellowship Program. Dr. Ghosh’s research interest is in bone marrow trans-plantation and cellular therapies to treat lymphoma. Dr. Ghosh will be seeing patients on the BMT service. Dr. Ghosh is rated as an Advanced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). Her top areas of expertise are Follicular Lymphoma, Graft Versus Host Disease (GvHD), Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Colonoscopy.

My past and ongoing research is focused on translational studies and clinical trials for children with brain and spinal cord tumors with a special emphasis on ependymoma and ATRT. Children with brain tumors continue to have poor outcomes compared to those with other cancers in this age group. I have analyzed the outcomes of treatment for ATRT and ependymoma in children, combining traditional modes of therapy, such as surgery, chemotherapy, and radiation therapy, with molecularly targeted therapy. In the process we have identified novel clinical and molecular risk factors associated with outcomes. By identifying clinical risk factors associated with poor outcomes in these children, we can tailor therapy to improve outcomes in those at highest risk of treatment failures. Dr. Upadhyaya is rated as an Advanced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Rhabdoid Tumor, Teratoma of the Mediastinum, Glioma, Medulloblastoma, and Bone Marrow Aspiration.

Dr. Magenau is currently an Assistant Professor at the University of Michigan and the Adult Clinical BMT director of the Blood and Marrow Transplantation Program. He holds a Bachelor of Science in Biology from Pennsylvania State University, and obtained his M.D. from the Temple University in Philadelphia, Pennsylvania. Dr. Magenau then trained in internal medicine at the University of Illinois in Chicago.Dr. Magenau is the lead clinical investigator on several trials including experience in clinical HCT, responsible research practices, team science, and conducting multicenter prospective HCT clinical trials in high risk populations (Acute Myeloid Leukemia not in remission at time of HCT). He also has a background in developing, performing, and monitoring HCT studies that integrate immune analysis of human samples. Dr. Magenau is rated as an Advanced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Graft Versus Host Disease (GvHD), Multiple Myeloma, Richter Syndrome, Bone Marrow Transplant, and Bone Marrow Aspiration.

Dr. Andrea (Flynn) Franson received her bachelor's degree from Rensselaer Polytechnic Institute in Troy, New York and her medical degree from the University of Michigan Medical School. She completed her residency in pediatrics and fellowship in pediatric hematology/oncology at the Children's Hospital of Philadelphia (CHOP). During fellowship, she earned a master's degree in Pharmacology from Thomas Jefferson University in Philadelphia. While at CHOP, she was an Alex's Lemonade Stand Foundation Center of Excellence Scholar, through which she had mentored training in clinical trial design and pharmacology. Dr. Franson has focused her research efforts in translational research science, working to transition the most promising compounds into the clinic for children with cancer. Dr. Franson is rated as an Advanced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). Her top areas of expertise are Glioma, Diffuse Midline Glioma H3 K27M-Mutant, Medulloblastoma, Neuroblastoma, and Bone Marrow Aspiration.

Jayapalli Bapuraj is a Radiologist and a Neuroradiologist in Ann Arbor, Michigan. Dr. Bapuraj has been practicing medicine for over 42 years and is rated as an Advanced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Chiari Malformation, Chiari Malformation Type 1, Stroke, Posterior Fossa Decompression, and Gastrostomy.

Mark Chiang is a Hematologist and an Internal Medicine provider in Ann Arbor, Michigan. Dr. Chiang is rated as an Advanced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Schnitzler Syndrome, Acute Lymphoblastic Leukemia (ALL), Adult T-Cell Leukemia, and Adult Immune Thrombocytopenia.

Darren King is a Hematologist and an Oncologist in Ann Arbor, Michigan. Dr. King has been practicing medicine for over 18 years and is rated as an Advanced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Graft Versus Host Disease (GvHD), Bone Marrow Transplant, and Bone Marrow Aspiration.